Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19Simona Tripon, Michel Doffoël, Thibaut Fabacher et al.|Clinics and Research in Hepatology and Gastroenterology|2022Cited by 15